The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by a selective degeneration of motor neurons, atrophy, and paralysis of skeletal muscle. Although a significant proportion of familial ALS results from a toxic gain of function associated with dominant SOD1 mutations, the etiology of the disease and its specific cellular origins have remained difficult to define. Here, we show that muscle-restricted expression of a localized insulin-like growth factor (Igf) -1 isoform maintained muscle integrity and enhanced satellite cell activity in SOD1G93A transgenic mice, inducing calcineurin-mediated regenerative pathways. Muscle-specific expression of local Igf-1 (mIgf-1) isoform also stabilized neuromuscular junctions, reduced inflammation in the spinal cord, and enhanced motor neuronal survival in SOD1G93A mice, delaying the onset and progression of the disease. These studies establish skeletal muscle as a primary target for the dominant action of inherited SOD1 mutation and suggest that muscle fibers provide appropriate factors, such as mIgf-1, for neuron survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Musarò, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E. R., L Sweeney, H., & Rosenthal, N. (2001) · Nature Genetics · doi:10.1038/84839 · Cited by 1,137 · cited 5×
“In contrast, the mIgf-1 isoform used in our present and previous studies (Barton-Davis et al., 1998; Musarò et al., 2001; Barton et al., 2002; Musarò et al., 2004) does not enter the circulation, but accumulates in the tissue of synthesis where its autocrine/paracrine function is concentrated.”
BackgroundMethodInfluentialSelf-citationWild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type
Chin, E. R., Olson, E. N., Richardson, J. A., Yang, Q., Humphries, C., Shelton, J. M., Wu, H., Zhu, W., Bassel-Duby, R., & Williams, R. S. (1998) · Genes & Development · doi:10.1101/gad.12.16.2499 · Cited by 1,011
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872 · cited 4×
“Retrograde transport of the AAV–Igf-1 vector to the spinal cord was reported necessary to achieve therapeutic effects (Kaspar et al., 2003).”
BackgroundMethodInfluentialBarton-Davis, E. R., Shoturma, D. I., Musaro, A., Rosenthal, N., & Sweeney, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15603 · Cited by 700
Self-citationMusarò, A., McCullagh, K. J. A., Naya, F. J., Olson, E. N., & Rosenthal, N. (1999) · Nature · doi:10.1038/23060 · Cited by 652
Self-citationHall, E. D., Oostveen, J. A., & Gurney, M. E. (1998) · Glia · doi:10.1002/(sici)1098-1136(199807)23:3<249::aid-glia7>3.0.co;2-# · Cited by 489
Cited by
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Vande Velde, C., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,429
Ageing and neuronal vulnerability
Mattson, M. P., & Magnus, T. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1886 · Cited by 957
Friedman, B. A., Srinivasan, K., Ayalon, G., Meilandt, W. J., Lin, H., Huntley, M. A., Cao, Y., Lee, S.-H., Haddick, P. C. G., Ngu, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.066 · Cited by 662
Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy
Yoshida, T., & Delafontaine, P. (2020) · Cells · doi:10.3390/cells9091970 · Cited by 714
Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity
Dobrowolny, G., Aucello, M., Rizzuto, E., Beccafico, S., Mammucari, C., Bonconpagni, S., Belia, S., Wannenes, F., Nicoletti, C., Del Prete, Z., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.002 · Cited by 513
Self-citationTransgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
TURNER, B., & TALBOT, K. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.001 · Cited by 496
Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors
Borselli, C., Storrie, H., Benesch-Lee, F., Shvartsman, D., Cezar, C., Lichtman, J. W., Vandenburgh, H. H., & Mooney, D. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903875106 · Cited by 447
The “Dying-Back” Phenomenon of Motor Neurons in ALS
Dadon-Nachum, M., Melamed, E., & Offen, D. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9467-1 · Cited by 412
Reactive Oxygen Species in Skeletal Muscle Signaling
Barbieri, E., & Sestili, P. (2012) · Journal of Signal Transduction · doi:10.1155/2012/982794 · Cited by 411
Molecular and cellular mechanisms of skeletal muscle atrophy: an update
Fanzani, A., Conraads, V. M., Penna, F., & Martinet, W. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-012-0074-6 · Cited by 370
Zanou, N., & Gailly, P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1330-4 · Cited by 360
Neurovascular signalling defects in neurodegeneration
Zacchigna, S., Lambrechts, D., & Carmeliet, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2336 · Cited by 345
IGF-I specifically enhances axon outgrowth of corticospinal motor neurons
Özdinler, P. H., & Macklis, J. D. (2006) · Nature Neuroscience · doi:10.1038/nn1789 · Cited by 341
“IGF-I enhances survival of spinal motor neurons in the spinal cor”
BackgroundWong, M., & Martin, L. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq106 · Cited by 314
Moloney, E. B., de Winter, F., & Verhaagen, J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00252 · Cited by 307
Delivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
IGF-1, inflammation and stem cells: interactions during muscle regeneration
MOURKIOTI, F., & ROSENTHAL, N. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.002 · Cited by 272
Self-citationPelosi, L., Giacinti, C., Nardis, C., Borsellino, G., Rizzuto, E., Nicoletti, C., Wannenes, F., Battistini, L., Rosenthal, N., Molinaro, M., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7690com · Cited by 268
Self-citationSuzuki, M., McHugh, J., Tork, C., Shelley, B., Hayes, A., Bellantuono, I., Aebischer, P., & Svendsen, C. N. (2008) · Molecular Therapy · doi:10.1038/mt.2008.197 · Cited by 262
Wu, D.-C., Ré, D. B., Nagai, M., Ischiropoulos, H., & Przedborski, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603670103 · Cited by 252
Effects of IGF-1 isoforms on muscle growth and sarcopenia
Ascenzi, F., Barberi, L., Dobrowolny, G., Villa Nova Bacurau, A., Nicoletti, C., Rizzuto, E., Rosenthal, N., Scicchitano, B. M., & Musarò, A. (2019) · Aging Cell · doi:10.1111/acel.12954 · Cited by 250
“For immunofluorescence analysis, EDL muscle sections were fixed with 4% PFA and processed as described (Dobrowolny et al., 2005).”
MethodSelf-citationImpaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS rat
Nicaise, C., Mitrecic, D., Demetter, P., De Decker, R., Authelet, M., Boom, A., & Pochet, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.018 · Cited by 168
Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156
Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
Cappello, V., & Francolini, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102092 · Cited by 119
“Another factor that causes a reduction in the level and efficacy of circulating IGF-1 is inflammation and it is known that aging is accompanied by a chronic mild inflammatory state sustained by increased levels of inflammatory cytokines, like interleukin 6 (IL-6), interleukin 1 (IL-1), tumor necrosis factor α (TNFα),…”
BackgroundInfluentialCrippa, V., D’Agostino, V. G., Cristofani, R., Rusmini, P., Cicardi, M. E., Messi, E., Loffredo, R., Pancher, M., Piccolella, M., Galbiati, M., et al. (2016) · Scientific Reports · doi:10.1038/srep22827 · Cited by 101
Impaired Mitophagy Plays a Role in Denervation of Neuromuscular Junctions in ALS Mice
Rogers, R. S., Tungtur, S., Tanaka, T., Nadeau, L. L., Badawi, Y., Wang, H., Ni, H.-M., Ding, W.-X., & Nishimune, H. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00473 · Cited by 83
“We analyzed the SOD1G93A mice at three stages: presymptomatic stage (P57) (Wooley et al., 2005; Hayworth and Gonzalez-Lima, 2009), a stage with denervation (P85) (Dobrowolny et al., 2005), and a symptomatic stage (P140) (Dobrowolny et al., 2005; Hayworth and Gonzalez-Lima, 2009).”
BackgroundMethodInfluentialPhysical Exercise-Induced Myokines in Neurodegenerative Diseases
Lee, B., Shin, M., Park, Y., Won, S.-Y., & Cho, K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115795 · Cited by 79
“Anti-inflammation Astrocyte activation ↓ TNF-α expression ↓ SOD1-G93A mice crossed with MLC/mIgf-1 transgenic mice [233]”
Basal lamina changes in neurodegenerative disorders
Nguyen, B., Bix, G., & Yao, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00502-y · Cited by 75
Skeletal muscle mTORC1 regulates neuromuscular junction stability
Baraldo, M., Geremia, A., Pirazzini, M., Nogara, L., Solagna, F., Türk, C., Nolte, H., Romanello, V., Megighian, A., Boncompagni, S., et al. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12496 · Cited by 76
“Indeed, activation of mTORC1 signalling by muscle-specific overexpression of IGF-1 is sufficient to ameliorate the overall pathogenesis and even prolongs lifespan in both ALS and SBMA.13,14 These results suggest that maintaining mTORC1 signalling in skeletal muscle is important for the maintenance of the whole neuromu…”
BackgroundFinelli, M. J., Sanchez-Pulido, L., Liu, K. X., Davies, K. E., & Oliver, P. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.685222 · Cited by 76
Campanari, M.-L., García-Ayllón, M.-S., Ciura, S., Sáez-Valero, J., & Kabashi, E. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00160 · Cited by 69
Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system
Vickers, J. C., King, A. E., Woodhouse, A., Kirkcaldie, M. T., Staal, J. A., McCormack, G. H., Blizzard, C. A., Musgrove, R. E. J., Mitew, S., Liu, Y., et al. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.004 · Cited by 69
Differential autophagy power in the spinal cord and muscle of transgenic ALS mice
Crippa, V., Boncoraglio, A., Galbiati, M., Aggarwal, T., Rusmini, P., Giorgetti, E., Cristofani, R., Carra, S., Pennuto, M., & Poletti, A. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00234 · Cited by 63
Camerino, G. M., Fonzino, A., Conte, E., De Bellis, M., Mele, A., Liantonio, A., Tricarico, D., Tarantino, N., Dobrowolny, G., Musarò, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39676-3 · Cited by 38
Self-citationDobrowolny, G., Bernardini, C., Martini, M., Baranzini, M., Barba, M., & Musarò, A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00463 · Cited by 29
Self-citationROCK inhibition improves axonal regeneration in a preclinical model of amyotrophic lateral sclerosis
Joshi, A. R., Muke, I., Bobylev, I., & Lehmann, H. C. (2019) · Journal of Comparative Neurology · doi:10.1002/cne.24679 · Cited by 27
“In contrast, we used a therapeutic approach by treating mice in which apparent symptoms of the disease started to develop at around 16 weeks (Alves et al., 2011; Dobrowolny et al., 2005).”
MethodMuscle-Bone Crosstalk in Amyotrophic Lateral Sclerosis
Zhou, J., Yi, J., & Bonewald, L. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0281-0 · Cited by 15
Metadata
- Authors
- Dobrowolny, G., Giacinti, C., Pelosi, L., Nicoletti, C., Winn, N., Barberi, L., Molinaro, M., Rosenthal, N., & Musarò, A.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2005-01-17
- Volume
- 168
- Issue
- 2
- Pages
- 193-199
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2131017387
- Cited by
- 354
- References
- 21
- FWCI
- 17.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.